## Abstract Amikacin (600 mg/m^2^/day IV) and ticarcillin (12 gm/m^2^/day IV) were administered to 38 children with cancer, neutropenia (< 1,000 PMN/mm^3^), and fever (β₯ 38Β°C) during 46 febrile episodes. Sixtyβone percent of the children were severely neutropenic (<200 PMN/mm^3^). Febrile episodes
Economic aspects of empiric antibiotic therapy for febrile neutropenia in children with cancer
β Scribed by E. Castagnola; Dimitri Paola; Raffaella Giacchino; Rossella Rossi; Claudio Viscoli
- Publisher
- Springer-Verlag
- Year
- 1998
- Tongue
- English
- Weight
- 60 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0941-4355
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background Recent investigations of febrile neutropenia in pediatric cancer patients have identified subsets of lowβrisk patients who can be managed with less antibiotic therapy than previously recommended standards. ## Methods and Materials PubMed and Medline were searched for pr
## BACKGROUND. Children with cancer who develop an episode of chemotherapyinduced febrile neutropenia usually are admitted to the hospital for intravenous empiric antibiotic therapy. In the current study, the authors examined the use of ciprofloxacin as outpatient management in selected patients wi